Author: OurCrowd

[Biolojic in Business Wire] Aulos Bioscience advances AU-007 to phase 2 portion of phase 1/2 study evaluating computationally designed IL-2 antibody for treatment of solid tumors

Dec 18, 2023 |

LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today announced plans to initiate the Phase 2 portion of its Phase 1/2 clinical trial of AU-007 in patients with unresectable locally advanced or metastatic solid tumor cancers of the skin and kidney. AU-007 is a human IgG1 monoclonal antibody designed using artificial intelligence to harness the power of interleukin-2 (IL-2) to eradicate solid tumors. Read...

Read More

[Sfara in PR Web] Sfara upgrades SDK, further enhancing technology, and now offering the only complete telematics solution for insurance carriers

Dec 15, 2023 |

HOBOKEN, N.J., Dec. 15, 2023 /PRNewswire-PRWeb/ — As a result of rising repair costs—therefore premiums—the insurance industry is facing increasingly tough economic challenges, both today and into tomorrow. The goal of claims digitization is a long-desired path to economic reward. Many leading carriers and industry analyst believe at the heart of this goal resides superior telematics solutions, with smartphone-based FNOL, that can be deployed to all policy holders. Read more...

Read More